Gilead Sciences, Inc. (NASDAQ: GILD) reported Q2 EPS of $0.99, $0.04 better than the analyst estimate of $0.95. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.29 billion.

For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.

Earnings